The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the true impact of the negotiations, BMO Capital Markets analysts said.

The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare. It's part of the federal government's first-ever drug pricing negotiations, a cost reduction it ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers in 2022 with the Inflation Reduction Act. The law ...

Most major camera brands have now adjusted list prices in the US – but now it appears Sony has adjusted the list price on several camera bodies for a second time. Initially spotted by Sony Alpha Rumors, the list price on several Sony bodies now sits ...

HousingWire Data shows that 42% of properties on the market have had a price reduction, while just 2% have seen price increases.

After months of failed litigation from drugmakers, CMS released negotiated list prices for 10 of the country’s most expensive drugs. The Inflation Reduction Act, signed into law in August 2022, granted CMS authority to negotiate the price of drugs with ...

The residential real estate market is slowly shaking off the cobwebs of a sluggish year of buying and selling, and quick-thinking homebuyers stand a good chance of snapping up a property at a lower price than in 2024—if they know where to look.

CMS’ newly released maximum fair prices include list-price reductions of 38% to 85% for 15 widely used medicines beginning in 2027. ・JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk,